PUBLISHER: The Business Research Company | PRODUCT CODE: 1760716
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760716
SNP genotyping and analysis involves detecting and studying single nucleotide polymorphisms (SNPs) variations at a single base pair in the genome across different individuals or populations. This is done using techniques such as PCR, microarrays, or sequencing. The process allows researchers to explore genetic diversity, track inheritance patterns, and gain insights into individual variations in drug responses or susceptibility to certain conditions.
The main sample types used in SNP genotyping and analysis include genomic DNA, RNA, cell-free DNA (cfDNA), plasma, and whole blood. Genomic DNA refers to the complete set of genetic material in an organism, which holds all the instructions needed for its growth and functioning. Various technologies are used to conduct the analysis, including microarrays, gene chips, TaqMan allelic discrimination, SNP pyrosequencing, Applied Biosciences SNPlex, and Sequenom MassArray MALDI-TOF. These methods serve different applications such as disease diagnostics, pharmacogenomics, precision medicine, forensic science, and agriculture. The target users for these technologies include hospitals, research labs, pharmaceutical and biotech companies, diagnostic labs, as well as academic and government institutions.
The SNP genotyping and analysis market research report is one of a series of new reports from The Business Research Company that provides SNP genotyping and analysis market statistics, including SNP genotyping and analysis industry global market size, regional shares, competitors with an SNP genotyping and analysis market share, detailed SNP genotyping and analysis market segments, market trends and opportunities, and any further data you may need to thrive in the SNP genotyping and analysis industry. This SNP genotyping and analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The SNP genotyping and analysis market size has grown rapidly in recent years. It will grow from $15.45 billion in 2024 to $18.65 billion in 2025 at a compound annual growth rate (CAGR) of 20.7%. The growth observed during the historical period can be credited to factors such as increased funding for biomedical research, the expansion of personalized medicine efforts, the rise of agricultural genomics, the high prevalence of chronic diseases, and the emergence of commercial genomic services.
The SNP genotyping and analysis market size is expected to see rapid growth in the next few years. It will grow to $39.41 billion in 2029 at a compound annual growth rate (CAGR) of 20.6%. The growth during the forecast period is expected to be driven by the expansion of population genomics initiatives, a stronger emphasis on diagnosing rare diseases, the rise in companion diagnostics and precision oncology, growing demand for direct-to-consumer (DTC) genomics, and regulatory support for genomic medicine. Key trends anticipated for the forecast period include advancements in genotyping technologies, the integration of artificial intelligence and bioinformatics, growth in oncology research, increased use in forensic and ancestry testing, and the development of portable genotyping devices.
The rising prevalence of genetic diseases is anticipated to drive the growth of the SNP genotyping and analysis market. Genetic diseases are caused by abnormalities in DNA, which may either be inherited from one or both parents or occur due to mutations during cell division. As awareness grows and diagnostic technologies improve, more genetic disorders are being recognized and diagnosed, contributing to the increasing burden of genetic diseases. SNP genotyping and analysis play a crucial role in this by identifying genetic variations linked to disease risk, progression, and drug responses, enabling early diagnosis and personalized treatment. For example, according to a report published by Cystic Fibrosis Australia in February 2024, the number of people living with cystic fibrosis in Australia increased to 3,738 in 2022, up from 3,616 in 2021. As a result, the growing burden of genetic diseases is expected to fuel the growth of the SNP genotyping and analysis market.
Leading companies in the SNP genotyping and analysis market are focusing on creating advanced solutions, such as large-scale low-pass whole genome sequencing for agricultural molecular breeding. Agricultural whole genome sequencing involves decoding the complete genetic material of crops or livestock to improve traits such as yield, disease resistance, and environmental adaptability. For instance, in June 2024, MGI Tech, a biotechnology company based in China, introduced an efficient whole workflow solution for large-scale agricultural low-pass whole genome sequencing. This solution, designed for molecular breeding genotyping of agricultural diploid species, includes DNA extraction, library preparation, sequencing, and SNP & InDel calling. It utilizes MGI's DNBSEQ-T7 and DNBSEQ-G400 sequencers, offering ultra-high throughput and flexibility, alongside pig reference panels and data analysis software to streamline genotyping without the need for custom database creation.
In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, acquired Verogen, Inc. The acquisition aims to enhance QIAGEN's leadership in human identification and forensics by integrating Verogen's advanced NGS tools and bioinformatics solutions into its existing portfolio. Verogen, a U.S.-based biotechnology company, specializes in SNP genotyping and analysis, offering tools such as the Forenseq Kintelligence kit and universal analysis software for forensic applications.
Major players in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International.
North America was the largest region in the SNP genotyping and analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in SNP genotyping and analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the SNP genotyping and analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The SNP genotyping and analysis market consists of revenues earned by entities by providing services such as DNA extraction and quality control, whole genome SNP analysis, SNP chip services, genetic association studies, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The SNP genotyping and analysis market also includes sales of genotyping platforms, genotyping assays/kits, bioinformatics software, Axiom genome-wide arrays, and bioinformatics analysis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
SNP Genotyping And Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on snp genotyping and analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for snp genotyping and analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The snp genotyping and analysis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.